GFM
JAZZ icon

GF Fund Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

GF Fund Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314K Sell
1,305
-59
-4% -$12.9K ﹤0.01% 236
2026
Q1 		$258K Buy
1,364
+170
+14% +$29.7K ﹤0.01% 266
2025
Q4 		$203K Sell
1,194
-111
-9% -$17K ﹤0.01% 291
2025
Q3 		$172K Sell
1,305
-243
-16% -$29.1K ﹤0.01% 304
2025
Q2 		$164K Hold
1,548
– – ﹤0.01% 335
2025
Q1 		$192K Buy
1,548
+279
+22% +$36.4K ﹤0.01% 318
2024
Q4 		$156K Buy
+1,269
New +$150K ﹤0.01% 303

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

GF Fund Management's JAZZ Position: Q2 2026 in Review

GF Fund Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 4.3% in Q2 2026, selling an estimated $12.9K and leaving 1,305 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #236.

GF Fund Management first reported a position in JAZZ in Q4 2024 and has held it in 7 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • GF Fund Management held 1,305 shares of Jazz Pharmaceuticals worth $314K as of Q2 2026.
  • GF Fund Management sold 59 Jazz Pharmaceuticals shares in Q2 2026, an estimated $12.9K.
  • Jazz Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #236 holding.
  • GF Fund Management first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.